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Introduction
Genetic background
Calpainopathy is the most common autosomal recessive 
l imb-girdle muscular dystrophy (LGMD). Due to 
their heterogeneity, the occurrence of the LGMDs is 
difficult to assess. Estimates report a prevalence ranging 
from 1 in 14,500 to 1 in 123,000 (1-3). On the basis of 
immunohistochemical and genetic examinations, the 
overall frequency of the LGMDs is of 5–70 cases/million 
population (4-9). According to the inheritance pattern, 
LGMDs are classified to dominant (LGMD1) and recessive 
forms (LGMD2). Calpainopathy is defined as limb-girdle 
muscular dystrophy type 2A (LGMD2A). Depending on 
the population examined, calpainopathy accounts for about 
26–30% of the LGMD cases. There are populations, such 
as that in the Basque region of Spain or Reunion Island, 
where it represents as many as 80%, whereas in Denmark, 
it accounts for only 6% of all of the LGMD cases (9).
LGMD2A is caused by mutations in the gene CAPN3 
located on chromosome 15q15.1-q21.1. CAPN3 gene 
encodes the 94-kDa non-lysosomal calcium-dependent 
cysteine protease, calpain 3. More than 300 mutations of 
the gene have so far been identified; however, genotype-
phenotype correlations could not yet be found. Intra- and 
interfamilial phenotypic variability have been described 
(3,10,11). The function of calpain 3 has not been 
completely elucidated. Calpain 3 has been suggested to be 
involved in the maturation of contractile elements after 
muscle degeneration (12). Calpain 3 interacts with titin and 
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dysferlin, and is presumed to play a role in the function 
of the dysferlin protein complex. Calpain-deficiency has 
been shown to cause sarcomere abnormality and it leads 
to muscle fiber death, whereas its functional impairment 
affects muscle membrane remodeling and repair (13,14).
Disease course
The disease begins in childhood, usually by the age of 8–15, 
with the reported ages of onset ranging between 2 and 
40 years. Early motor milestones are usually normal. Toe 
walking is common and can be the presenting sign, but the 
earliest signs are usually attributable to the involvement of 
the hip adductors and the gluteus maximus (9,10,13).
The most common appearance is that of scapular, 
pelvic girdle, and trunk weakness, with facial muscles 
being generally spared. Muscle weakness is generalized 
and symmetrical, being more pronounced proximally 
and relatively mild distally. Hip-girdle weakness is the 
most pronounced in the gluteus maximus and in the hip 
adductors, leading to a wide-based, lordotic gait, whereas 
the involvement of the scapular muscles leads to scapular 
winging (present in 83% of all cases). Abdominal muscles 
(i.e., rectus abdominis) are also involved (10). These features 
together with the involvement of the elbow flexors and the 
sparing of the respiratory muscles are considered specific 
for LGMD2A (15). The atrophy of the involved muscles is 
prominent. Hypertrophy can also occur in some patients. 
Contractures develop with time and are also considered 
characteristic. As the respiratory muscles are spared, the 
vital capacity rarely declines below 80% and no nocturnal 
hypoventilation has been observed. Cardiac involvement 
has not yet been reported (16). The progression of the 
disease is slow and the patients become wheelchair-bound at 
11–28 years after the onset of the disease, generally by the 
age of 40. The earlier the onset of the disease, the more 
rapid the progression (10). 
Several phenotypes have been described, including the 
limb-girdle type, the Leyden-Moebius type with pelvic-
femoral involvement, the Erb dystrophy type with scapular-
humeral involvement, and the Miyoshi muscular dystrophy 
phenotype (3,10). A severe Duchenne-like form and a form 
with significant contractures similar to that seen in Emery-
Dreifuss muscular dystrophy have also been described (9). 
Distal muscle weakness (foot drop) has also been reported 
as the initial symptom of calpainopathy (17). Calpainopathy 
can also present as an asymptomatic hyperCKemia in 
10–14% of cases (9,10). 
Diagnosis and treatment
The diagnosis of the disease is based on the clinical 
presentation, the elevated CK levels, and the findings 
of electromyography, muscle biopsy, and molecular 
genetic testing. Muscle biopsy shows fiber-size variation, 
interstitial fibrosis, an enhanced internalization of nuclei, 
and occasionally the presence of eosinophils owing to 
the upregulation of interleukin-32 and immunoglobulin 
genes (13). 
Immunohistochemical staining reveals a decreased 
immunoreactivity for the 60-kD and/or the 30-kD band 
of calpain 3 by Western blot. The reduction or the loss of 
staining for the 60-kD band is more specific and sensitive 
than that for the 30-kD band, whereas the loss of staining 
for both bands is highly specific for LGMD2A. However, 
about 25% of patients have normal staining. A decreased 
immunohistochemical reactivity for dysferlin can also occur 
in calpainopathy, whereas a reduced calpain 3 staining 
may be present in other LGMDs as well, such as 1C, 
2B, 2I, J, and the dystrophinopathies (9). Genetic testing 
shows an autosomal recessive mutation in chromosome 
15, at 15q15.1. More than 150 mutations have so far been 
identified, including missense mutations, early stop codons, 
splicing defects, small insertions or deletions, and large 
genomic deletions at various locations along the gene (10). 
There is at present no treatment available for LGMDs. 
Supportive care aims at preserving muscle function, 
maintaining functional ability, delaying the development 
of skeletal abnormalities and contractures, prolonging 
ambulation, and increasing the life expectancy. If necessary, 
orthopedic procedures can be recommended to maintain 
ambulation and independence. Annual cardiological 
evaluation is advisable.
We present a case with calpainopathy in which 
cardiac involvement has been extensively investigated by 
routine Doppler echocardiography, extended with three-
dimensional speckle-tracking echocardiography (3DSTE).
Case presentation
The 43-year-old male patient was first investigated at the 
age of 12 for an abnormal gait. His first complain was 
walking tiptoe. Later, proximal weakness occurred in the 
upper and lower extremities, with difficulty lifting arms, 
climbing stairs, and walking, accompanied by a waddling, 
lordotic gait. Muscle atrophy developed in the limb-girdle 
muscles. No muscle hypertrophy was observed. Achillotomy 
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was performed at age 12, resulting in improved gait. He 
became wheelchair-bound by the age of 38. For another 
2 years, he was still able to stand up with help, but was 
unable to walk. He also has mildly elevated levels of 
cholesterol and a mild hypertension. His family history is 
negative for muscle disease. On neurological examination, 
he currently presents with a symmetrical tetraparesis 
and muscle atrophy, the latter being more pronounced 
proximally. Muscle strength in the upper extremities is 
2/5 proximally and in the elbow flexors, and 3/5 to 4/5 
distally. In the lower extremities, muscle strength is 1/5 
to 2/5 proximally, being the most pronounced in the hip 
adductors, and 3/5 in the distal muscles. Severe symmetrical 
muscle atrophy can be seen.
He was diagnosed at the age of 12 with limb-girdle 
muscle dystrophy. CK levels were mildly elevated, 
ranging between 488 and 700 U/L (normal up to 
195 U/L). Muscle biopsy was first performed at age 12 
and showed a myopathic pattern, with no specific changes. 
The second muscle biopsy performed at age 19 revealed 
a dystrophinopathy, and the diagnosis of Becker muscular 
dystrophy was presumed. Later (at age 38) the diagnosis 
was re-evaluated. The molecular genetic test performed did 
not confirm the presumed Becker muscular dystrophy and 
Pompe disease was also ruled out as an etiology underlying 
the muscle weakness. The clinical course of the disease 
raised the suspicion of calpainopathy. Molecular genetic 
testing revealed a homozygous deletion (C550delA) in exon 
4 of the CAPN3 gene. The diagnosis of LGMD2A was 
established at age 39. The patient is regularly examined by a 
neurologist and has annual cardiology check-ups.
The patient was enrolled into the MAGYAR-Path 
Study (Motion Analysis of the heart and Great vessels bY 
three-dimensionAl speckle-tRacking echocardiography 
in Pathological cases), in which, among other factors, the 
potential diagnostic and prognostic significance of 3DSTE-
derived variables were assessed in different pathological 
conditions (18).  Routine cardiological examination 
included physical examination, ECG, 2D Doppler 
echocardiography, and 3DSTE. In addition to routine 
cardiac echocardiographic examination using a Toshiba 
Artida ultrasound machine (Toshiba Medical Systems, 
Tokyo, Japan), a 3D dataset was digitally collected for 
offline chamber quantification using a PST-25SX matrix-
array transducer with 3DSTE capability. Description of 
3DSTE analysis of the left ventricular (LV) was detailed 
in a previous study (19). Briefly, three short-axis views and 
the apical 4-chamber (AP4CH) and 2-chamber (AP2CH) 
views extracted from 3D echocardiographic datasets were 
analyzed offline using the 3D Wall Motion Tracking 
software version 2.5 (Toshiba Medical Systems). Following 
the manual marking of two points in the endocardium at 
the edges of the mitral valve and one point at the apex on 
the AP4CH and AP2CH views, the endocardial 3D surface 
was automatically detected, tracked, and reconstructed 
throughout the cardiac cycle. Using the created LV-
3D model, several strain and rotational curves were 
generated for the quantification of LV global and segmental 
deformations from the volumetric data (Figure 1).
No chest pain or any signs suggestive of cardiovascular 
abnormalities were found in the past medical history of 
the patient or revealed on physical examination. On ECG, 
normofrequent sinus rhythm with normal repolarization 
was found, and echocardiography revealed normal 
chamber dimensions with an ejection fraction (EF) of 
61%. Diastolic dysfunction could not be confirmed (E/A = 
67/45, E wave deceleration time =168 ms) and only low-
grade mitral and aortic regurgitations were demonstrated 
by Doppler echocardiography. LV hypertrophy was not 
observed. 3DSTE-derived LV global radial, longitudinal, 
circumferential, and area strains were reduced (−20.2%, 
−10.8%, −25.6%, and −37.1%, respectively). Apical LV 
rotation was found to be severely increased (14.4 degree), 
whereas basal LV rotation proved to be normal (−3.8 
degree), resulting in an increased LV twist (18.2 degree) in 
this case.
Discussion
Advances have been made in the diagnosis of muscle 
dystrophies, and in cases without previously established 
genetic diagnosis, re-evaluation of the diagnosis should be 
considered. In the present case, the presumed diagnosis 
was that of Becker muscular dystrophy; however, this could 
not be proven by molecular genetic testing. On the basis 
of the clinical picture and the clinical course suggestive of 
calpainopathy, molecular genetic testing was performed, 
revealing a homozygous deletion (C550delA) in exon 4 of 
the CAPN3 gene. Based on a large study, in the case of a 
characteristic phenotype, the probability that a patient has 
LGMD2A is 90% when there is no calpain detectable in 
the Western blot. However, the characteristic phenotype 
was found to be a more accurate predictor compared 
to the Western blot in case of patients for whom either 
the phenotype or the protein analysis was suggestive of 
calpainopathy (20). This emphasizes the importance of the 
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examination and follow-up by an experienced neurologist in 
the diagnostic work-up of patients with muscle dystrophies. 
Our patient undergoes annual cardiological evaluation 
aiming at the assessment of cardiac involvement by 3DSTE.
3DSTE is a novel development in echocardiography, 
allowing the parallel assessment of volumetric cyclic 
changes and the analysis of deformation via strain 
assessments of heart chambers, by the use of the same 
3D model created from the same digitally acquired 3D 
dataset (18). Exact validated volumetric and functional 
parameters can be assessed at the same time within a 
relatively short period of time, followed by a detailed 
analysis of the volumetric and functional features of 
the atria and ventricles (21). In addition to volumetric 
measurements, deformation parameters, including the uni- 
and multidirectional strains of the LV, quantitative features 
of LV contractility, can be assessed together with parameters 
characterizing LV rotational mechanics. In the past, only 
different invasive techniques, including microsonometry 
or tagged magnetic resonance imaging were suitable for 
the quantification of LV rotations and twist; however, 
due to their invasive nature, availability, and cost, their 
determination remained problematic (22). 3DSTE solved 
this problem, allowing the assessment of quantitative 
deformation features and rotational mechanics at the 
same time (18). Normally, the LV base rotates clockwise, 
whereas the LV apex rotates counterclockwise, due to the 
fact that myocardial fibers on the subepicardial side run in 
a left-handed direction (22,23). Their net sum is called the 
LV twist, which is responsible for approximately 40% of 
the LV pumping function during systole, as evidenced by 
physiological studies. However, myocardial fibers on the 
subendocardial side run in a right-handed direction, and 
the contraction of these fibers causes an opposite rotation: 
Figure 1 Apical 4-chamber (A) and 2-chamber (B) views and short-axis views (C3, C5, C7) at different levels of the LV extracted from 
the three-dimensional (3D) echocardiographic dataset are presented. A 3D cast of the LV and calculated volumetric and functional LV 
parameters (such as EDV, ESV, EF, estimated LV mass) are also demonstrated. Counterclockwise hyperrotation of the LV apex and 
clockwise rotation (within normal range) of the LV base are also shown in the patient with calpainopathy. LV, left ventricular; EDV, end-
diastolic volume; ESV, end-systolic volume; EF, ejection fraction.
689Quantitative Imaging in Medicine and Surgery, Vol 7, No 6 December 2017
© Quantitative Imaging in Medicine and Surgery. All rights reserved. Quant Imaging Med Surg 2017;7(6):685-690qims.amegroups.com
the base rotates counterclockwise whereas the apex rotates 
clockwise. The radius of the rotation of the subepicardium 
is greater than that of subendocardium, providing a greater 
torque, which results in a significantly expressed rotation of 
the subepicardium. In case of a subepicardial dysfunction, 
the rotation decreases, whereas in case of a subendocardial 
dysfunction, the rotation increases. There are confusing 
results about LV rotational mechanics in heart failure with 
preserved EF (22). Some authors found hyperrotation 
in association with abnormal relaxation (subendocardial 
dysfunction) and hyporotation in association with 
advanced diastolic dysfunction (24), whereas other authors 
reported that LV twisting does not decrease with diastolic 
dysfunction (25). In the presented case with calpainopathy, 
routine echocardiographic examination did not confirm 
systolic or diastolic heart failure. However, over reduced LV 
strains, significantly increased LV apical rotation and LV 
twist were found indicating asymptomatic subclinical (latent) 
LV dysfunction (26-29). 
To the best of the authors’ knowledge, this is the first 
study in which the investigation of the cardiac involvement 
in calpainopathy revealed reduced LV strains and increased 
LV apical rotation and twist. We found no factors that 
could theoretically underlie the observed alteration in LV 
rotational mechanics in the present case, but the effect of 
comorbidities, the applied medications or other factors 
could not be fully excluded. Further examinations are 
warranted to confirm our findings and to find a correct 
pathophysiological explanation.
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